Research progress in drug therapy for bronchopulmonary dysplasia in preterm infants.
- Author:
Yu-Chen YANG
1
;
Jian MAO
;
Juan LI
Author Information
1. Department of Neonatology, Shengjing Hospital of China Medical University, Shenyang 110004, China. yuchen0508@163.com.
- Publication Type:Journal Article
- From:
Chinese Journal of Contemporary Pediatrics
2018;20(1):67-71
- CountryChina
- Language:Chinese
-
Abstract:
Bronchopulmonary dysplasia (BPD) is the most common long-term complication in surviving extremely preterm infants. This may lead to pulmonary hypertension, increase late neonatal mortality, and cause abnormal neural development. There is still controversy over the efficacy, as well as advantages and disadvantages, of drug therapy for BPD in preterm infants. This article reviews the research progress in the drug therapy for BPD.
